tylenol sinus severe
Generic: acetaminophen, guaifenesin, and phenylephrine hydrochloride
Labeler: navajo manufacturing company inc.Drug Facts
Product Profile
Brand Name
tylenol sinus severe
Generic Name
acetaminophen, guaifenesin, and phenylephrine hydrochloride
Labeler
navajo manufacturing company inc.
Dosage Form
TABLET, COATED
Routes
Active Ingredients
acetaminophen 325 mg/1, guaifenesin 200 mg/1, phenylephrine hydrochloride 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
67751-239
Product ID
67751-239_435b5b96-73d0-4d01-e063-6394a90ae4dd
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M012
Listing Expiration
2026-12-31
Marketing Start
2025-02-19
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67751239
Hyphenated Format
67751-239
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tylenol sinus severe (source: ndc)
Generic Name
acetaminophen, guaifenesin, and phenylephrine hydrochloride (source: ndc)
Application Number
M012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 325 mg/1
- 200 mg/1
- 5 mg/1
Packaging
- 1 POUCH in 1 CARTON (67751-239-01) / 2 TABLET, COATED in 1 POUCH
- 2 POUCH in 1 CARTON (67751-239-02) / 2 TABLET, COATED in 1 POUCH
Packages (2)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "435b5b96-73d0-4d01-e063-6394a90ae4dd", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["362O9ITL9D", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1243679"], "spl_set_id": ["435b4a2a-d6bf-ec25-e063-6294a90a3f06"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Navajo Manufacturing Company Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (67751-239-01) / 2 TABLET, COATED in 1 POUCH", "package_ndc": "67751-239-01", "marketing_start_date": "20250219"}, {"sample": false, "description": "2 POUCH in 1 CARTON (67751-239-02) / 2 TABLET, COATED in 1 POUCH", "package_ndc": "67751-239-02", "marketing_start_date": "20250219"}], "brand_name": "Tylenol Sinus Severe", "product_id": "67751-239_435b5b96-73d0-4d01-e063-6394a90ae4dd", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "67751-239", "generic_name": "Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride", "labeler_name": "Navajo Manufacturing Company Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Tylenol Sinus Severe", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250219", "listing_expiration_date": "20261231"}